JP2005503396A5 - - Google Patents

Download PDF

Info

Publication number
JP2005503396A5
JP2005503396A5 JP2003524565A JP2003524565A JP2005503396A5 JP 2005503396 A5 JP2005503396 A5 JP 2005503396A5 JP 2003524565 A JP2003524565 A JP 2003524565A JP 2003524565 A JP2003524565 A JP 2003524565A JP 2005503396 A5 JP2005503396 A5 JP 2005503396A5
Authority
JP
Japan
Prior art keywords
alkyl
fluorine
substituted
alkenyl
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003524565A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005503396A (ja
JP4342306B2 (ja
Filing date
Publication date
Priority claimed from DE10142668A external-priority patent/DE10142668A1/de
Application filed filed Critical
Publication of JP2005503396A publication Critical patent/JP2005503396A/ja
Publication of JP2005503396A5 publication Critical patent/JP2005503396A5/ja
Application granted granted Critical
Publication of JP4342306B2 publication Critical patent/JP4342306B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003524565A 2001-08-31 2002-08-17 肥満症の予防用または治療用医薬の製造のためのc2−置換インダン−1−オン系化合物の使用 Expired - Fee Related JP4342306B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10142668A DE10142668A1 (de) 2001-08-31 2001-08-31 Verwendung von C2-substituierten Indan-1-on-Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas
PCT/EP2002/009208 WO2003020256A1 (de) 2001-08-31 2002-08-17 Verwendung von c2-substituierten indan-1-on-systemen zur herstellung von medikamenten zur prophylaxe oder behandlung von obesitas

Publications (3)

Publication Number Publication Date
JP2005503396A JP2005503396A (ja) 2005-02-03
JP2005503396A5 true JP2005503396A5 (https=) 2006-01-05
JP4342306B2 JP4342306B2 (ja) 2009-10-14

Family

ID=7697238

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003524565A Expired - Fee Related JP4342306B2 (ja) 2001-08-31 2002-08-17 肥満症の予防用または治療用医薬の製造のためのc2−置換インダン−1−オン系化合物の使用

Country Status (10)

Country Link
US (1) US6946492B2 (https=)
EP (1) EP1424999A1 (https=)
JP (1) JP4342306B2 (https=)
AU (1) AU2002336985B2 (https=)
CA (1) CA2458555A1 (https=)
DE (1) DE10142668A1 (https=)
IL (2) IL160607A0 (https=)
MX (1) MXPA04001853A (https=)
PE (1) PE20030336A1 (https=)
WO (1) WO2003020256A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101746867B1 (ko) * 2009-01-26 2017-06-14 타이페이 메디컬 유니이버시티 당뇨 및 비만을 치료하기 위한 프테로신 화합물의 용도
CN103333144B (zh) * 2013-06-17 2014-12-10 温州大学 一种2-硫基-3-卤代苯并呋喃化合物及其合成方法和用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0009554B1 (de) * 1978-07-27 1983-04-27 Schering Aktiengesellschaft Indanyl-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate
WO1989003681A1 (en) * 1987-10-19 1989-05-05 Pfizer Inc. Substituted tetralins, chromans and related compounds in the treatment of asthma
WO1997020802A1 (en) * 1995-12-06 1997-06-12 Venantius Limited Indane dimer compounds and their pharmaceutical use
AU727775B2 (en) 1996-01-17 2000-12-21 Novo Nordisk A/S Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use
IL128332A0 (en) 1996-08-30 2000-01-31 Novo Nordisk As GLP-1 derivatives
IL127296A (en) 1996-12-31 2003-01-12 Reddy Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
PL338013A1 (en) 1997-07-16 2000-09-25 Novo Nordisk As Derivatives of condensed 1,2,4-thiadiazine, their production and application
EA004229B1 (ru) * 1999-03-01 2004-02-26 Пфайзер Продактс Инк. Оксаминовые кислоты и их производные в качестве лигандов тиреоидных рецепторов
FR2796070B1 (fr) * 1999-07-06 2003-02-21 Lipha Derives de benzodiazepines utilisables dans le traitement de dyslipidemies, de l'atherosclerose et du diabete, compositions pharmaceutiques les contenant et procedes de preparation
EP1078632A1 (en) 1999-08-16 2001-02-28 Sanofi-Synthelabo Use of monoamine oxydase inhibitors for the manufacture of drugs intended for the treatment of obesity

Similar Documents

Publication Publication Date Title
JP2007534702A5 (https=)
EP1798226A4 (en) TRAIZOL DERIVATIVE
JP2005539088A5 (https=)
JP2005053931A5 (https=)
TN2009000024A1 (en) Prodrug of cinnamide compound
NO20062758L (no) Polycykliske midler for behandling av respiratorisk syncytial virus infeksjoner
CA2487542A1 (en) Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides
JP2007508362A5 (https=)
NO20062517L (no) 2-cyanopyrrolidinkarboksamidforbindelse
JP2004535412A5 (https=)
JP2003535128A5 (https=)
NO20090270L (no) Cinnamoyl-piperazinederivater og deres anvendelse som PAR-I-antagonister
JP2007519618A5 (https=)
DK1447400T3 (da) Bicyklisk forbindelse
ATE475413T1 (de) Mittel gegen radikale
NO20042010L (no) 4-imidazolin-2-on forbindelser
JPH10316662A5 (https=)
NO20082226L (no) 6-heteroarylpyridoindolonderivater, deres fremstilling og terapeutisk anvendelse derav
JP2005503396A5 (https=)
MXPA04003935A (es) Derivados de piridina como bloqueadores del subtipo de receptores n-metil-d-aspartato.
JP2005529869A5 (https=)
NO20065902L (no) 3-{4-(pyridin-3-yl)fenyl}-5-(1H-,1,2,3-triazol-1-ylmetyl)-1,3-oksazolidin-2-oner som antibakterielle midler
JP2006515276A5 (https=)
DE602004032130D1 (de) 4-imidazolin-2-onverbindungen
JP2005525295A5 (https=)